Amit Keiran John Mandal

Amit Keiran John Mandal

Auto-generated profile, based on publicly available information

Amit Keiran John Mandal

Departments of Medicine and Cardiology, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Berkshire, United Kingdom

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2020 in Postgraduate Medical Journal
Verified
Journal Article
Open access
PDF file
VBVadir Baktash
Vadir Baktash
THTom Hosack
Tom Hosack
NPNishil Patel
Nishil Patel
SSShital Shah
Shital Shah
PKPirabakaran Kandiah
Pirabakaran Kandiah
CMConstantions G Missouris
Constantions G Missouris
Purpose Older adults are more likely to be vitamin D deficient. The aim of the study was to determine whether these patients have worse outcomes with COVID-19. Methods We conducted a prospective cohort study between 1 March and 30 April 2020 to assess the importance of vitamin D deficiency in older patients with COVID-19. The cohort consisted of patients aged ≥65 years presenting with symptoms consistent with COVID-19 (n=105). All patients were tested for serum 25-hydroxyvitamin D (25(OH)D) levels during acute illness. Diagnosis of COVID-19 was confirmed via viral reverse transcriptase PCR swab or supporting radiological evidence. COVID-19-positive arm (n=70) was sub-divided into vitamin D-deficient (≤30 nmol/L) (n=39) and -replete groups (n=35). Subgroups were assessed for disease severity using biochemical, radiological and clinical markers. Primary outcome was in-hospital mortality. Secondary outcomes were laboratory features of cytokine storm, thoracic imaging changes and requirement of non-invasive ventilation (NIV). Results COVID-19-positive arm demonstrated lower median serum 25(OH)D level of 27 nmol/L (IQR=20–47 nmol/L) compared with COVID-19-negative arm, with median level of 52 nmol/L (IQR=31.5–71.5 nmol/L) (p value=0.0008). Among patients with vitamin D deficiency, there was higher peak D-dimer level (1914.00 μgFEU/L vs 1268.00 μgFEU/L) (p=0.034) and higher incidence of NIV support and high dependency unit admission (30.77% vs 9.68%) (p=0.042). No increased mortality was observed between groups. Conclusion Older adults with vitamin D deficiency and COVID-19 may demonstrate worse morbidity outcomes. Vitamin D status may be a useful prognosticator.

21 September 2020 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
PDF file
JGJasmine Ming Gan
Jasmine Ming Gan
JKJason Kho
Jason Kho
MAMichelle Akhunbay-Fudge
Michelle Akhunbay-Fudge
HCHwei Ming Choo
Hwei Ming Choo
MWMelanie Wright
Melanie Wright
CMConstantinos G. Missouris
Constantinos G. Missouris
Background It is increasingly recognised that older patients may not present with typical symptoms of COVID-19. Aims This study aims to evaluate the incidence, characteristics and clinical outcome of older adults with atypical presentations of COVID-19. Methods A retrospective analysis of adults ≥ 65 years with confirmed COVID-19 admitted to our institution between 1 March and 24 April 2020 was performed. Patients were categorised into typical or atypical groups based on primary presenting complaint in the community. Results One hundred twenty-two patients (mean age 81 ± 8 years; 62 male) were included. Seventy-three (60%) were categorised into the typical group and 49 (40%) into the atypical group. In the atypical group, common presenting complaints were fall in 18 (36%), reduced mobility or generalised weakness in 18 (36%) and delirium in 11 (22%). Further assessment by paramedics and on admission found 32 (65%) to have typical features of COVID-19, fever being the most common, and 22 (44%) were hypoxic. This subset had worse outcomes than those in the typical group with a mortality rate of 50% versus 38%, respectively, although this was not statistically significant (P = 0.27). No significant difference in mortality or length of hospital stay between the groups was demonstrated. Conclusion Older patients with atypical presentation of COVID-19 in the community are equally susceptible to poor outcomes. Early detection may improve outcomes and limit community transmission. Primary care practitioners should be vigilant and consider prompt onward referral.

18 June 2021 in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
Verified
Journal Article
Closed access
PDF file
RHRandeep S Heer
Randeep S Heer
AMAmit K J Mandal
Amit K J Mandal
JKJason Kho
Jason Kho
PSPiotr Szawarski
Piotr Szawarski
PCPeter Csabi
Peter Csabi
CMConstantinos G Missouris
Constantinos G Missouris
Background: The variability of Covid-19 severity between patients has driven efforts to identify prognosticating laboratory markers that could aid clinical decision-making. Procalcitonin is classically used as a diagnostic marker in bacterial infections, but its role in predicting Covid-19 disease severity is emerging. We aimed to identify the association between procalcitonin and Covid-19 disease severity in a critical care setting and whether bacterial co-infection is implicated. Methods: We retrospectively reviewed Covid-19 patients with procalcitonin concentrations measured in a critical care setting at our institution between February and September 2020. Laboratory markers including peak procalcitonin values and a range of bacterial culture results were analysed. Outcomes were the requirement and duration of invasive mechanical ventilation as well as inpatient mortality. Results: In total, 60 patients were included; 68% required invasive mechanical ventilation and 45% died as inpatient. Univariate analysis identified higher peak procalcitonin concentrations significantly associated with both the requirement for invasive mechanical ventilation (OR: 3.2, 95% CI 1.3–9.0, P = 0.02) and inpatient mortality (OR: 2.6, 95% CI 1.1–6.6, P = 0.03). Higher peak procalcitonin concentrations was an independent predictor of mortality on multivariate analysis (OR 3.7, 95% CI 1.1–12.4, P = 0.03). There was a significant positive correlation between increased peak procalcitonin concentrations and duration on invasive mechanical ventilation. No significant difference was found between peak procalcitonin concentrations of patients with positive and negative bacterial cultures. Conclusions: Elevated procalcitonin concentrations in Covid-19 patients are associated with respiratory failure requiring prolonged invasive mechanical ventilation and inpatient mortality. This association may be independent of bacterial co-infection.

5 April 2023 in Aging Medicine
Verified
Journal Article
Open access
HWHo Lun Wong
Ho Lun Wong
CWClaire Weaver
Claire Weaver
LMLauren Marsh
Lauren Marsh
KMKhine Oo Mon
Khine Oo Mon
JDJohn M. Dapito
John M. Dapito
CMConstantions G Missouris
Constantions G Missouris
Introduction: Polypharmacy is a growing phenomenon associated with adverse effects in older adults. We assessed the potential confounding effects of cumulative anticholinergic burden (ACB) in patients who were hospitalized with falls.Methods: A noninterventional, prospective cohort study of unselected, acute admissions aged ≥ 65 years. Data were derived from electronic patient health records. Results were analyzed to determine the frequency of polypharmacy and degree of ACB and their relationship to falls risk. Primary outcomes were polypharmacy, defined as prescription of 5 or more regular oral medications, and ACB score.Key Results: Four hundred eleven (411) consecutive subjects were included, mean age 83.8 ± 8.0 years: 40.6% men. There were 38.4% patients who were admitted with falls. Incidence of polypharmacy was 80.8%, (88.0% and 76.3% among those admitted with and without fall, respectively). Incidence of ACB score of 0, 1, 2, ≥ 3 was 38.7%, 20.9%, 14.6%, and 25.8%, respectively. On multivariate analysis, age [odds ratio (OR) = 1.030, 95% CI:1.000 ~ 1.050, P = 0.049], ACB score (OR = 1.150, 95% CI:1.020 ~ 1.290, P = 0.025), polypharmacy (OR = 2.140, 95% CI:1.190 ~ 3.870, P = 0.012), but not Charlson Comorbidity Index (OR = 0.920, 95% CI:0.810 ~ 1.040, P = 0.172) were significantly associated with higher falls rate. Of patients admitted with falls, 29.8% had drug‐related orthostatic hypotension, 24.7% had drug‐related bradycardia, 37.3% were prescribed centrally acting drugs, and 12.0% were taking inappropriate hypoglycemic agents.Conclusion: Polypharmacy results in cumulative ACB and both are significantly associated with falls risk in older adults. The presence of polypharmacy and each unit rise in ACB score have a stronger effect of increasing falls risk compared to age and comorbidities.

15 June 2020 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
JTJessica M. Toombs
Jessica M. Toombs
KAKoenraad Van Den Abbeele
Koenraad Van Den Abbeele
JDJane Democratis
Jane Democratis
RMRhona Merricks
Rhona Merricks
AMAmit K. J. Mandal
Amit K. J. Mandal
CMConstantinos G. Missouris
Constantinos G. Missouris
Click on the article title to read more.

8 July 2020 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
JTJessica M. Toombs
Jessica M. Toombs
KAKoenraad Van Den Abbeele
Koenraad Van Den Abbeele
JDJane Democratis
Jane Democratis
AMAmit K. J. Mandal
Amit K. J. Mandal
CMConstantinos G. Missouris
Constantinos G. Missouris
Click on the article title to read more.